Table 1.

Distribution of valvular regurgitation at initial echocardiogram in 4825 women exposed to fenfluramine and/or dexfenfluramine

	Ages
	<20 (n = 25)	20–29 (n = 386)	30–39 (n = 900)	40–49 (n = 1442)	50–59 (n = 1279)	60–69 (n = 610)	70+ (n = 183)	All ages (n = 4825)
Aortic regurgitation
none (%)	96.0	85.8	75.4	65.4	59.5	59.8	53.6	66.3
trace (%)	4.0	10.1	14.7	17.6	19.9	20.7	29.5	17.8
mild (%)	0	3.1	7.8	11.2	13.4	12.8	11.5	10.7
moderate (%)	0	1.0	2.0	5.1	6.6	5.7	4.9	4.7
severe (%)	0	0	0.11	0.62	0.55	0.98	0.55	0.50
Mitral regurgitation
none (%)	64.0	42.2	36.4	29.8	24.9	22.6	18.6	29.6
trace (%)	32.0	50.8	50.7	54.4	54.3	54.1	48.6	53.0
mild (%)	4.0	4.9	10.3	11.2	13.9	13.6	13.1	11.6
moderate (%)	0	1.8	2.2	4.2	5.5	8.7	15.3	4.9
severe (%)	0	0.26	0.33	0.49	1.5	0.98	4.4	0.91
Tricuspid regurgitation
none (%)	56.0	22.8	24.4	22.8	21.1	18.4	15.3	22.0
trace (%)	28.0	63.5	60.3	62.1	60.0	62.1	60.1	61.1
mild (%)	16.0	11.9	12.6	12.1	12.9	11.5	12.6	12.3
moderate (%)	0	1.8	2.6	2.5	5.2	6.6	10.4	4.0
severe (%)	0	0	0.11	0.55	0.70	1.5	1.6	0.62